In the same study, oestradiol-induced TUBB3 expression could not be reproduced in estrogen receptor (ER) negative breast cancer cell lines, and was abrogated after exposure to the ER antagonists tamoxifen and fulvestrant in several ER-expressing breast cancer cell lines. Here, TUBB3 is linked to breast carcinoma.